Drug Management of Prostate Cancer

Prostate cancer is the most common noncutaneous prostate cancer. deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer.